Roger Graham has been appointed president of Mylan Specialty and will report to Tony Mauro, president of Mylan North America. Mr. Graham joins the company from Advandx, a private developer of in-vitro diagnostic tests in the infectious disease space, where he served as chief commercial officer and developed its growth strategy for the U.S. and European markets. Prior to that, he spent nearly a decade in executive-level marketing and sales positions at three brand pharmaceutical firms, Auxilium...